A novel angiopoietin-derived peptide displays anti-angiogenic activity and inhibits tumour-induced and retinal neovascularization
Open Access
- 22 September 2011
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 165 (6), 1891-1903
- https://doi.org/10.1111/j.1476-5381.2011.01677.x
Abstract
No abstract availableKeywords
This publication has 63 references indexed in Scilit:
- Diabetic Retinopathy: Targeting VasoregressionDiabetes, 2011
- Chemical generation of bispecific antibodiesProceedings of the National Academy of Sciences of the United States of America, 2010
- Complementary Actions of Inhibitors of Angiopoietin-2 and VEGF on Tumor Angiogenesis and GrowthCancer Research, 2010
- Peptides modulating conformational changes in secreted chaperones: From in silico design to preclinical proof of conceptProceedings of the National Academy of Sciences of the United States of America, 2009
- Angiopoietin 2 Is a Partial Agonist/Antagonist of Tie2 Signaling in the EndotheliumMolecular and Cellular Biology, 2009
- Vascular endothelial growth factor in eye diseaseProgress in Retinal and Eye Research, 2008
- Angiopoietin-4 Inhibits Angiogenesis and Reduces Interstitial Fluid PressureNeoplasia, 2006
- Sustained Angiopoietin-2 Expression Disrupts Vessel Formation and Inhibits Glioma GrowthNeoplasia, 2006
- Signaling and Functions of Angiopoietin-1 in Vascular ProtectionCirculation Research, 2006
- Angiopoietin-1 Inhibits Endothelial Cell Apoptosis via the Akt/Survivin PathwayJournal of Biological Chemistry, 2000